<DOC>
	<DOCNO>NCT00302666</DOCNO>
	<brief_summary>The aim study evaluate bleeding pattern , cycle control , contraceptive efficacy safety oral contraceptive two different regimen intake .</brief_summary>
	<brief_title>Bleeding Pattern Study</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany . Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<criteria>Healthy female volunteer age 18 40 year require contraception . Pregnancy lactation . Any condition might interfere outcome well contraindication OC use .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Contraception , Bleeding pattern</keyword>
</DOC>